Cancer Epidemiology
Volume 36, Issue 1 , Pages 11-15 , February 2012

Time trends in testicular cancer in Croatia 1983–2007: Rapid increases in incidence, no declines in mortality

  • Nino Sincic

      Affiliations

    • Laboratory for Epigenetics and Molecular Medicine, Department of Medical Biology, University of Zagreb Medical School, Zagreb, Croatia
    • ,
  • Tomislav Kulis

      Affiliations

    • Department of Urology, University Hospital Centre Zagreb, Zagreb, Croatia
    • ,
  • Ariana Znaor

      Affiliations

    • Croatian National Cancer Registry, Croatian National Institute of Public Health, Zagreb, Croatia
    • Andrija Stampar School of Public Health, University of Zagreb Medical School, Zagreb, Croatia
    • Corresponding Author InformationCorresponding author at: Croatian National Cancer Registry, Rockefellerova 7, 10000 Zagreb, Croatia. Tel.: +385 1 486 32 80; fax: +385 1 486 32 71.
    • ,
  • Freddie Bray

      Affiliations

    • Section of Cancer Information, International Agency for Research on Cancer, Lyon, France

Received 14 April 2011 ,Revised 22 September 2011 ,Accepted 27 September 2011.

References 

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase no. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010;Available from: http://globocaniarcfr
  2. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer. 2005;115(5):822–827
  3. Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer. 2006;118(12):3099–3111
  4. Holmes L, Escalante C, Garrison O, Foldi BX, Ogungbade GO, Essien EJ, et al. Testicular cancer incidence trends in the USA (1975–2004): plateau or shifting racial paradigm?. Public Health. 2008;122(9):862–872
  5. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003;97(1):63–70
  6. Matsuda T, Saika K. Comparison of time trends in testicular cancer incidence (1973–97) in East Asia, Europe and USA, from cancer incidence in five continents, vols. IV–VIII. Jpn J Clin Oncol. 2008;38(8):578–579
  7. Baade P, Carriere P, Fritschi L. Trends in testicular germ cell cancer incidence in Australia. Cancer Causes Control. 2008;19(10):1043–1049
  8. Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005;116(3):331–339
  9. Lind GE, Skotheim RI, Lothe RA. The epigenome of testicular germ cell tumors. APMIS. 2007;115(10):1147–1160
  10. Schulz WA, Hoffmann MJ. Transcription factor networks in embryonic stem cells and testicular cancer and the definition of epigenetics. Epigenetics. 2007;2(1):37–42
  11. Korkola JE, Heck S, Olshen AB, Reuter VE, Bosl GJ, Houldsworth J, et al. In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosomes Cancer. 2008;47(1):43–55
  12. Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med. 2009;169(4):351–356
  13. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer. 2000;87(3):438–443
  14. Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA. A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer – experiences of the mother. Int J Epidemiol. 2009;38(6):1532–1542
  15. Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA. A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer – experiences of the son. Int J Epidemiol. 2010;39(6):1605–1618
  16. Huddart RA. Survival from testicular cancer in England and Wales up to 2001. Br J Cancer. 2008;99(Suppl. 1):S83–S85
  17. Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977;87(3):293–298
  18. Dearnaley D, Huddart R, Horwich A. Regular review: managing testicular cancer. BMJ. 2001;322(7302):1583–1588
  19. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999 Results and commentary. Eur J Cancer. 2009;45(6):931–991
  20. In:  Curado MP,  Edwards B,  Shin HR,  Storm H,  Ferlay J,  Heanue M, et al. editor. Cancer incidence in five continents, vol. IX. Lyon: IARC; 2007;[IARC Scientific Publications No. 160]
  21. In:  Parkin DM,  Whelan SL,  Ferlay J,  Raymond L,  Young J editor. Cancer incidence in five continents, vol. VII. Lyon: IARC; 1997;[IARC Scientific Publications No. 143]
  22. In:  Parkin DM,  Whelan SL,  Ferlay J,  Teppo L,  Thomas DB editor. Cancer incidence in five continents, vol. VIII. Lyon: IARC; 2002;[IARC Scientific Publications No. 155]
  23. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents: a technical report. New York: Springer; 1966;
  24. In:  Segi M,  Kurihara M editor. Cancer mortality for selected sites in 24 countries (1950–1957). 2nd ed.. Sendai: Tohoku University of Medicine; 1960;
  25. National Cancer Institute . Joinpoint regression program. 3.4.2 ed.. Bethesda: Statistical Research and Applications Branch, National Cancer Institute; 2009;
  26. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351
  27. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II. Age–period–cohort models. Stat Med. 1987;6(4):469–481
  28. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I. Age–period and age–cohort models. Stat Med. 1987;6(4):449–467
  29. Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst. 1996;88(11):727–733
  30. Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol. 2006;3(10):532–543
  31. Pike MC, Chilvers CE, Bobrow LG. Classification of testicular cancer in incidence and mortality statistics. Br J Cancer. 1987;56(1):83–85
  32. Richiardi L, Bellocco R, Adami HO, Torrang A, Barlow L, Hakulinen T, et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2157–2166
  33. Jacobsen R, Moller H, Thoresen SO, Pukkala E, Kjaer SK, Johansen C. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl. 2006;29(1):199–204
  34. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International Trends in the Incidence of Testicular Cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1151–1159
  35. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5(3):210–222
  36. Bray F, Richiardi L, Ekbom A, Forman D, Pukkala E, Cuninkova M, et al. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age–period–cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev. 2006;15(4):652–658
  37. Bertuccio P, Malvezzi M, Chatenoud L, Bosetti C, Negri E, Levi F, et al. Testicular cancer mortality in the Americas, 1980–2003. Cancer. 2007;109(4):776–779
  38. Boyle P. Testicular cancer: the challenge for cancer control. Lancet Oncol. 2004;5(1):56–61
  39. Harding MJ, Paul J, Gillis CR, Kaye SB. Management of malignant teratoma: does referral to a specialist unit matter?. Lancet. 1993;341(8851):999–1002

PII: S1877-7821(11)00151-2

doi: 10.1016/j.canep.2011.09.010

Cancer Epidemiology
Volume 36, Issue 1 , Pages 11-15 , February 2012

Article Tools

* Image Usage & Resolution